Skip to main navigation menu Skip to main content Skip to site footer
FrancoAngeli Journals

Saggi, Studi e Ricerche

No. 69 (2025)

The therapeutic community as place of care. Analysis of the outcomes of drug users’ community paths at the Ser.D of Portogruaro, in the five-year period 2017/2022

DOI
https://doi.org/10.3280/mis69-2025oa19253
Submitted
gennaio 24, 2025
Published
2025-05-20

Abstract

Objectives: This article aims to describe the outcomes of residential care pathways undertaken by patients diagnosed with substance use disorders, referred by the Ser.D. of Portogruaro (VE) to the therapeutic communities (CT) in Veneto, during the five-year period from 2017 to 2022.

Materials and methods: By analyzing the qualitative and quantitative data recorded in "Gedi" and "Geki", the two digital platforms used by the Services to manage patients, the study considered the residential care pathways of 77 patients and evaluated their retention in treatment, examining the last residential care pathway undertaken by each user. The differences in terms of retention in treatment between users with opioid use disorders and those with alcohol use disorders were then analyzed.

Results: The collected data show that dropping-out of the care pathway, particularly due to lack of compliance, is the most frequent outcome, with an average recorded stay of just over six months. Additionally, less than one-fifth of the users complete the therapeutic program.

Conclusions: The results suggest further research to explore the causes of dropout, due to prevent them, as longer retention in treatment is correlated with better outcomes of rehabilitation interventions.

References

  1. Bennett D., Pollock P., Ryle A. (2005). The States Description Procedure: the use of guided self‐reflection in the case formulation of patients with Borderline Personality Disorder. Clinical Psychology & Psychotherapy: An International Journal of Theory & Practice, 12(1), 50-57. http://dx.doi.org/10.1002/cpp.416
  2. Bignamini E., Cortese M., Garau S., Sansebastiano S. Dipendenza da sostanze e patologia psichiatrica. Percorsi di ricerca sulla comorbidità. Editeam, Castello d’Argile, 2002.
  3. Brown C.H., Bennett M.E., Li L., & Bellack A.S. (2011). Predictors of initiation and engagement in substance abuse treatment among individuals with co-occurring serious mental illness and substance use disorders. Addictive behaviors, 36(5), 439-447. http://dx.doi.org/10.1016/j.addbeh.2010.12.001
  4. Cacciola J.S., Alterman A.I., Rutherford M.J., McKay J.R., Mulvaney F.D. (2001). The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug Alcohol Depend; 61:271-80. https://doi.org/10.1016/S0376-8716(00)00148-4
  5. Calamai G. (2018). Uso e abuso di sostanze: Capire e affrontare le dipendenze da alcol e droghe. Edizioni Centro Studi Erickson, Trento.
  6. Carrà G., Johnson S., Bebbington P., Angermeyer M.C., Heider D., Bruga T., Azorin J-M, Toumi M. (2012). The lifetime and past-year prevalence of dual diagnosis in pepople with schizophrenia across Europe: Findings from the European Schizophrenia Cohort (EuroSC). In European Archives of Psychiatry and Clinical Neuroscience, 262, pp 607-616. https://doi.org/10.1007/s00406-012-0305-z
  7. Chianura P., Balzotti A., Chianura L. (2005). Comorbilità psichiatrica ed abuso di sostanze, Franco Angeli Editore, Milano.
  8. Coletti M., & Grosso L. (2022). La comunità terapeutica per persone tossicodipendenti. Associazione Gruppo Abele Onlus-Edizioni Gruppo Abele.
  9. De Witte N.A., Crunelle C.L., Sabbe B., Moggi F., & Dom G. (2014). Treatment for outpatients with comorbid schizophrenia and substance use disorders: a review. European addiction research, 20(3), 105-114. https://doi.org/10.1159/000355267
  10. Dipartimento Politiche antidroga – Presidenza del Consiglio dei Ministri. (2013). Indagine sul consumo di sostanze psicotrope nella popolazione italiana 18-64 anni. Report Drug 2014, 37-139.
  11. Dowd E. T., Rugle L. (2001) La tossicodipendenza: Trattamenti a confronto, McGraw-Hill, Milano
  12. Drake R.E., Mueser K.T., Clark R.E., Wallach M.A. (1996). The course, treatment, and outcome of substance disorder in person with severe mental illness. Am J Orthopsychiatry; 66:42-51. https://doi.org/10.1037/h0080153
  13. EMCDDA, «Co-morbid substance use and mental disorders in Europe: a review of the data », European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 2013. [En ligne]. Disponible su: https://www.emcdda.europa.eu/attachements.cfm/att_220660_EN_TDAU13002ENN.pdf
  14. Greenberg W.M., Otero J., Villanueva L. (1994). Irregular discharges from a dual diagnosis unit. Am J Drug Alcohol Abuse; 20:355-71. https://doi.org/10.3109/00952999409106020
  15. Haro G., Mateu C., Martinez Raga J., Valderrama J.C., Castellano M., Cervera G. (2004). The role of personality disorders on drug dependence treatment outcomes following inpatient detoxification. Eur Psychiatry; 19:187-92. https://doi.org/10.1016/j.eurpsy.2004.04.004
  16. Hillebrand, J. “Le pratiche di valutazione del trattamento della tossicodipendenza negli stati membri dell’unione europea”. Disponibile al sito: http://www.giovanniserpelloni.it/pdf/pdf277.pdf
  17. I SerD e i Dipartimenti delle Dipendenze, Dipartimento per le politiche antidroga. Disponibile al sito: https://www.politicheantidroga.gov.it/it/servizi-e-contatti-utili/serd/i-serd/
  18. Kelly T.M., Daley D.C., & Douaihy A.B. (2012). Treatment of substance abusing patients with comorbid psychiatric disorders. Addictive behaviors, 37(1), 11-24. https://doi.org/10.1016/j.addbeh.2011.09.010
  19. Kuntsche E., Rehm J. e Gmel G. (2004). Caratteristiche dei binge drinking in Europa. Scienze sociali e medicina, 59 (1), 113-127. https://doi.org/10.1016/j.socscimed.2003.10.009
  20. Manera R., Gallini P., Bellio G. & Fioritti A. (2007). Prevalenza della comorbilità psichiatrica in pazienti con dipendenza da oppiacei in un Ser.T del Veneto. Personalità/Dipendenze 13, 51-54.
  21. Martinez-Raga J., Marshall E.J., Keaney F., Best D., Ball D., Strang J. (2001). Hepatitis B and C in alcohol-dependent patients admitted to a UK alcohol inpatient treatment unit. Addict Biol; 6:363-72. https://doi.org/10.1080/13556210020077082
  22. Martinez-Raga J., Marshall E.J., Keaney F., Ball D., Strang J. (2002). Unplanned versus planned discharges from in-patient alcohol detoxification: retrospective analysis of 470 firstepisode admissions. Alcohol Alcohol; 37:277-81. https://doi.org/10.1093/alcalc/37.3.277
  23. Molin V., Pellegrini G., Ferrucci R., & Lovaste R. La Recidiva tossicomanica post comunitaria. Analisi di follow up degli inserimenti in CT 2004-2014 di pazienti con diagnosi di dipendenza da sostanze noti ai Ser. D. Trentini. Mission, 63.
  24. Moos R.H., Moos B.S., Finney J.W. (2001). Predictors of deterioration among patients with substance-use disorders. J Clin Psychol; 57:1403-19. https://doi.org/10.1002/jclp.1105
  25. Nava F., 2010. La doppia diagnosi e l'integrazione dei trattamenti fra criticità organizzative e gestionali: l'esperienza della Regione Veneto. In Lucchini A., Strepparola G. (Editors). Modelli di interventi in alcologia. L'esperienza e le indicazioni operative condivise degli operatori pubblici e privati in Lombardia, Franco Angeli Editore, Milano, 97-104.
  26. Rampazzo L., Corti A., Aguanno N., Banon D., Beltrame C., Cibin M., ... & Serpelloni G. (2004). La "Doppia Diagnosi" nel Veneto. Bollettino per le farmacodipendenze e l’alcolismo, (3-4).
  27. Ravndal E., Vaglum P. (1995). The influence of personality disorders on treatment completion in a hierarchical therapeutic community for drug abusers: a prospective study. Eur Addict Res; 1:178-86. https://doi.org/10.1159/000259081
  28. Rigliano P. (2015), “Doppia diagnosi. Tra tossicodipendenza e psicopatologia”, Raffaello Cortina Editore, Milano, 2015.
  29. Rigliano P., Bignamini E. (2009), (a cura di). Cocaina. Consumo, psicopatologia, trattamento. Raffaello Cortina Editore, Milano.
  30. Saccon D., Valdesalici A., Boatto E., et al. (2023). Retrospective study in a cohort of subjects with substance use disorders in Veneto, Italy: real-world outcomes of an addiction daytime program treatment. Evidence-based Psychiatric Care, 2023;9:7-14. https://doi.org/10.36180/2421-4469-2023-3
  31. Saccon D, Banon D, Boatto E. (2013). Evoluzioni nelle dipendenze da sostanze. Uno studio sul problema delle cronicizzazioni, scienze mediche, CLEUP, Padova
  32. Saccon D., Banon D., Boatto E., & Favaretto G. (2010). La “doppia diagnosi” nel Veneto: indagine sulla prevalenza nei Dipartimenti per le dipendenze. PSICHIATRIA DI COMUNITÀ. VOL. Ⅸ. 3-4 settembre-dicembre 2010.
  33. Saccon D., Banon D., Dal Ben G., (2008) Strutture “intermedie” nelle dipendenze e nella doppia diagnosi, Cleup, Padova
  34. Sanfilippo B. (2010). Newsletter “Clinica dell’Alcolismo”. Alcol, alcolismi e cronicità. Mission ,29.
  35. Vanderplasschen W., Colpaert K., Autrique M., Rapp R.C., Pearce S., Broekaert E., & Vandevelde S. (2013). Comunità terapeutiche per le dipendenze: una revisione della loro efficacia da una prospettiva orientata al recupero. The Scientific World Journal, 2013. https://doi.org/10.1155/2013/427817.

Metrics

Metrics Loading ...